Dosage form development, manufacture, and stability studies of GS-441524, period of performance 5/10/2021 - 6/30/2024.
Ended Awarded Last action
- Contract number
- 75N95021F00001
- Awardee
-
The University Of Iowa UEI Z1H9VJS8NG16
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $470,254
Award facts
- Opportunity
-
- 75N95021R00020 Solicitation number
- Contract value 100% obligated
- $470,254.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Iowa City, IA 52242, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $229,848 | |
| Other Administrative Action | $0 | |
| Original award | $240,406 |
About this award
This is a $470,254.00 Firm Fixed Price Delivery Order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to The University of Iowa. The contract is part of the NCATS Drug Product Development Studies 2017-2022 Indefinite Delivery Vehicle (IDV) contract, which allows NCATS to issue task orders for specialized research services.
This specific task order is for dosage form development, manufacturing, and stability studies of the drug compound GS-441524, with a period of performance from May 10, 2021 to June 30, 2024. The University of Iowa, a large public research institution, will perform the required work at its facilities in Iowa City, Iowa. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N95021F00001?
75N95021F00001 was awarded to The University Of Iowa by National Institute on Drug Abuse (National Institutes of Health) on May 10, 2021.
How much is contract 75N95021F00001 worth?
The government has obligated $470,254 on 75N95021F00001.
Which agency awarded contract 75N95021F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95021F00001 an order under another contract?
Yes. 75N95021F00001 is a delivery order under HHSN271201700019I, an indefinite delivery contract, on NCATS Drug Product Development Studies 2017-2022.
Was contract 75N95021F00001 competed?
The extent of competition for 75N95021F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award